MYO-SEQ Advanced

Within MYO-SEQ we identified an over-representation of patients carrying heterozygous variants in some of the LGMD recessive genes, namely CAPN3, DYSF, SGCA, SGCB, SGCD, SGCG and ANO5.

We propose that these patients might carry a second cryptic pathogenic variant. We carried out whole genome sequencing (WGS) to identify intronic or regulatory non-coding variants that may affect splicing and/or protein expression driving disease presentation.

Funding: Sarepta 

Ana Topf

Senior Research Associate

Basic Research

Adam McFarlane

Laboratory Technical Specialist

Basic Research

Cookie consent

We use some essential cookies to make this website work.

We also use cookies set by other sites to help us deliver content from their services, like fonts and maps.

For more details, please see our Cookie Policy